Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

SELL
$0.26 - $0.62 $130 - $310
-500 Reduced 63.61%
286 $0
Q3 2023

Nov 01, 2023

BUY
$0.4 - $1.39 $314 - $1,092
786 New
786 $0
Q1 2023

Apr 27, 2023

SELL
$0.42 - $1.4 $1,538 - $5,129
-3,664 Reduced 68.07%
1,719 $1,000
Q4 2022

Feb 02, 2023

BUY
$0.31 - $8.8 $484 - $13,745
1,562 Added 40.88%
5,383 $2,000
Q3 2022

Nov 04, 2022

SELL
$0.56 - $6.98 $1,639 - $20,430
-2,927 Reduced 43.38%
3,821 $2,000
Q2 2022

Aug 03, 2022

SELL
$0.63 - $1.22 $6,674 - $12,925
-10,595 Reduced 61.09%
6,748 $4,000
Q1 2022

May 02, 2022

BUY
$0.99 - $2.44 $5,140 - $12,668
5,192 Added 42.73%
17,343 $19,000
Q4 2021

Feb 23, 2022

SELL
$2.18 - $3.93 $13,343 - $24,055
-6,121 Reduced 33.5%
12,151 $27,000
Q3 2021

Oct 28, 2021

BUY
$2.71 - $4.35 $3,986 - $6,398
1,471 Added 8.76%
18,272 $79,000
Q2 2021

Aug 12, 2021

BUY
$2.94 - $4.75 $23,181 - $37,453
7,885 Added 88.44%
16,801 $64,000
Q1 2021

Apr 26, 2021

BUY
$3.99 - $5.53 $6,008 - $8,328
1,506 Added 20.32%
8,916 $38,000
Q4 2020

Feb 02, 2021

SELL
$2.99 - $5.79 $86,321 - $167,157
-28,870 Reduced 79.58%
7,410 $28,000
Q3 2020

Oct 14, 2020

BUY
$4.79 - $9.1 $56,162 - $106,697
11,725 Added 47.75%
36,280 $178,000
Q2 2020

Jul 13, 2020

SELL
$3.61 - $11.84 $63,730 - $209,023
-17,654 Reduced 41.83%
24,555 $176,000
Q1 2020

Apr 29, 2020

BUY
$2.56 - $6.14 $106,818 - $256,197
41,726 Added 8638.92%
42,209 $176,000
Q4 2019

Feb 05, 2020

SELL
$5.78 - $8.11 $63,400 - $88,958
-10,969 Reduced 95.78%
483 $2,000
Q3 2019

Oct 15, 2019

BUY
$6.55 - $9.36 $26,599 - $38,010
4,061 Added 54.95%
11,452 $94,000
Q2 2019

Jul 26, 2019

BUY
$5.92 - $9.47 $43,754 - $69,992
7,391 New
7,391 $69,000

Others Institutions Holding BSGM

About BioSig Technologies, Inc.


  • Ticker BSGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,814,400
  • Market Cap $60.1M
  • Description
  • BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...
More about BSGM
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.